FDA approves Novo Nordisk's new Wegovy HD injection
This approval for Wegovy further expands its already robust label inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines.
This approval for Wegovy further expands its already robust label inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines.
The spot anchors the company’s new “A New Way to Wegovy®” campaign, using humor to reshape weight management talks and challenge the idea that medication is “the easy way out.”
The 1.5 mg pill is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep it off.
Ro first integrated directly with Novo Nordisk in April 2025 and has been a key part of the manufacturer's direct-to-patient expansion to date.
Wegovy pill now broadly available through over 70,000 US pharmacies such as CVS and Costco.
Bundled offer includes Wegovy at $199 and LifeMD’s Virtual Weight Loss Program for a total first-month cost of $299, $599 per month thereafter.